Last $57.72 USD
Change Today +1.56 / 2.78%
Volume 330.8K
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for alkermes plc (ALKS)

Year over year, Alkermes plc has been able to grow revenues from $390.0M USD to $577.2M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold, SGA expenses and income tax expenses. These changes allowed the company to report positive net income, improving from a loss of $113.7M USD to a profit of $23.5M USD.
Currency in
Millions of US Dollars
As of:Mar 31
2010
Reclassified
Mar 31
2011
Reclassified
Mar 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues173.3186.6390.0577.2
Other Revenues5.0------
TOTAL REVENUES178.3186.6390.0577.2
Cost of Goods Sold49.452.2127.6171.9
GROSS PROFIT128.8134.5262.4405.3
Selling General & Admin Expenses, Total87.787.7113.6164.5
R&D Expenses84.291.2136.8161.8
Depreciation & Amortization, Total----25.451.2
OTHER OPERATING EXPENSES, TOTAL171.9179.0275.8377.5
OPERATING INCOME-43.0-44.5-13.427.9
Interest Expense-6.0-3.3-28.1-13.8
Interest and Investment Income4.72.71.50.9
NET INTEREST EXPENSE-1.3-0.6-26.6-12.9
Currency Exchange Gains (Loss)----0.50.3
Other Non-Operating Income (Expenses)-0.4-0.30.0-0.8
EBT, EXCLUDING UNUSUAL ITEMS-44.7-45.4-39.514.4
Merger & Restructuring Charges---1.1-29.1-7.2
Other Unusual Items, Total-----45.8--
EBT, INCLUDING UNUSUAL ITEMS-44.7-46.5-114.47.2
Income Tax Expense-5.1-1.0-0.7-16.3
Earnings from Continuing Operations-39.6-45.5-113.723.5
NET INCOME-39.6-45.5-113.723.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-39.6-45.5-113.723.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-39.6-45.5-113.723.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $57.72 USD +1.56

ALKS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $91.53 USD +3.35
Impax Laboratories Inc $31.99 USD +0.67
Jazz Pharmaceuticals PLC $166.55 USD +1.22
Pacira Pharmaceuticals Inc/DE $93.51 USD +1.42
Salix Pharmaceuticals Ltd $118.09 USD +3.17
View Industry Companies
 

Industry Analysis

ALKS

Industry Average

Valuation ALKS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.5x
Price/Book 6.3x
Price/Cash Flow 452.8x
TEV/Sales 13.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.